首頁 > 市場調查報告書 > 醫療設備

感測器

市場調查報告書

商品編碼

1606546

全球心電圖感測器市場 - 2024-2031

Global Electrocardiogram Sensors Market - 2024-2031

出版日期: 2024年12月04日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2023年，全球心電圖感測器市場規模達94.2億美元，預計2031年將達到154.1億美元，2024-2031年預測期間複合年成長率為6.4%。

心電圖感測器是評估心臟電活動的心臟狀況操作和診斷的重要組成部分。事實上，另一個重要功能包括檢測心律不整、心肌梗塞和其他心臟異常，這些功能需要透過醫療管道立即檢測和介入。從技術上講，心電圖感測器隨著時間的推移而不斷發展，從大型機器轉變為以智慧手錶、健身追蹤器和無線貼片等穿戴式裝置的形式緊湊使用，使人們能夠輕鬆存取和使用它們。心血管疾病的增加以及針對此的家庭或遠端監控和健身追蹤服務的需求將會增加。

市場動態：

驅動程式和限制

不斷進步的技術

在醫療保健環境中的可能應用的創新和擴展方面，技術進步將在世界心電圖 (ECG) 感測器市場上帶來巨大變革。例如，小型化、無線連接和人工智慧整合等進步使心電圖感測器在準確性方面更加強大，使它們更容易、更友善地操作。借助先進技術，穿戴式心電圖感測器現在可以進行即時監測、早期檢測低心律不整事件以及個人化的健康見解，使患者能夠遠端管理自己的心臟健康狀況。人工智慧驅動的演算法透過複雜的資料模式分析提高診斷精度，同時減輕醫療保健專業人員的負擔。

感測器材料和設計的創新，例如靈活的親膚貼片，提高了患者的舒適度和依從性。這些符合遠距醫療和家庭護理的新興趨勢，將心電圖感測器定位為現代醫療保健提供方式之一，但在加速市場成長方面發揮巨大作用。

例如，2023 年 8 月，芬蘭醫療設備製造商 Movesense 推出了一款輕型穿戴式心電圖感測器“Movesense Medical”，用於遠端患者監護和遠距醫療應用。 IIa 類設備根據歐盟醫療設備法規註冊，供遠距醫療保健提供者、製造商、醫院或開發自己的醫療設備的公司使用。

缺乏熟練的專業人員

能夠正確解釋心電圖資料的知識豐富的人員的可用性構成了全球心電圖 (ECG) 感測器市場的重要限制，特別是在醫療基礎設施薄弱的國家。感測器技術和人工智慧引入了各種創新，可以使心電圖監測變得更加簡單，但複雜心臟訊號的解釋通常必須由訓練有素的心臟科醫生或專家進行。

農村和偏遠地區的這種差距進一步限制了獲得此類專業知識的機會，從而限制了心電圖感測器安裝的有效性。此外，由於缺乏人工監督的驗證，自動化系統的過度依賴可能會導致誤診，進一步影響對這些設備的信任和採用。這種技能短缺和醫療資源分配不均更阻礙了心電圖感測器技術的採用、分配和使用。

ECG sensors are significant constituents of the operation and diagnosis of heart conditions in assessing the heart's electric activity. In fact, another important function includes those in the detection of arrhythmias, myocardial infarctions, and other cardiac abnormalities, which require immediate detection and intervention through medical channelization. Technologically speaking, ECG sensors have evolved over time, changing from large machines to compact use in the form of wearable gadgets like smartwatches, fitness trackers, and wireless patches, making them easy to access and use for people. An increment in cardiovascular diseases and increased demand for home or remote monitoring and fitness-tracking services geared towards that will build.

Market Dynamics: Drivers & Restraints

Increasing Technological Advancements

Advances in technology are set to revolutionize quite a lot in the world electrocardiogram (ECG) sensors market in terms of innovation and extension in possible applications among healthcare settings. For example, advancements like miniaturization, wireless connectivity, and artificial intelligence integration have made ECG sensors much more functional with regard to accuracy, making them easier and more friendly to handle. With the aid of advancement technologies, wearable ECG sensors now allow real-time monitoring, early detection of low arrhythmic events, and personalized health insights, enabling patients to manage their cardiac health from a distance. AI-driven algorithms improve diagnostic precision through complex data pattern analysis while relieving the healthcare professional's burden.

Innovations in sensor materials and designs, such as flexible skin-friendly patches, have brought about increased comfort and compliance with the patient. These are in line with the emergent trends of telemedicine and home-based care, positioning ECG sensors as among the modern healthcare delivery's modalities, but are playing a huge role in accelerating the growth of the market.

For instance, in August 2023, Finnish medical device manufacturer Movesense has introduced a lightweight wearable ECG sensor, 'Movesense Medical', for remote patient monitoring and telehealth applications. The Class IIa device is registered under the EU Medical Device Regulation and is intended for use by remote healthcare providers, manufacturers, hospitals, or companies developing their own medical devices.

Lack of Skilled Professionals

The availability of knowledgeable personnel who can correctly interpret the ECG data present forms an important limitation in the global electrocardiogram (ECG) sensors market, particularly in countries with poor healthcare infrastructure. Sensor technology and AI have introduced various innovations that can make ECG monitoring simpler, but the interpretation of complex cardiac signals often has to be carried out by trained cardiologists or specialists.

This gap in rural and isolated areas further confines access to such expertise, limiting the effectiveness of the ECG sensor installation. Besides, automated systems over-dependence may lead to misdiagnosis due to lack of validation by human oversight, further frowning on the trust and adoption of these devices. This skill shortage and unequal distribution of healthcare resources serve as yet more disincentives to the uptake, distribution, and use of ECG sensor technologies.

Segment Analysis

The global electrocardiogram sensors market is segmented based on product type, connectivity, application, end user and region.

Product type:

Wearable ECG sensors segment is expected to dominate the electrocardiogram sensors market share

The Wearable ECG sensors segment holds a major portion of the electrocardiogram sensors market share and is expected to continue to hold a significant portion of the electrocardiogram sensors market share during the forecast period.

The emergence of wearable ECG sensors will transform the whole electrocardiogram (ECG) sensors market beyond its limits by providing convenient real-time heart monitoring solutions. The demand for remote ongoing care is driving this trend further. Battery-powered miniature, user-friendly devices such as watches, patches, or fitness bands will allow users to continuously monitor their hearts. Especially for arrhythmias, chronic cardiac conditions, and preventive care, these devices will add value. State-of-the-art technologies give AI and Bluetooth-influenced advantages in the area of promising features such as accuracy multiple and easy availability to instant diagnosis.

The continuous advancement gives rise to the use of wearables in home settings with high demand because of an increase in cardiovascular diseases causing maximum consumer awareness of monitoring their health and hence the change towards home and personal healthcare solutions, plus the emergence of the technological landscape. Ultimately, the adoption of wearable ECG sensors resonates with global telemedicine and digital health trends that will not miss being accomplished for future modern needs of the health system and will contribute significantly to its market growth.

For instance, in October 2023, RMIT University in Australia has developed a lightweight, gel-free, and waterproof electrocardiogram (ECG) sensor that offers comfort and less skin irritation compared to other heart monitoring devices. The wearable ECG device, which weighs only 10 grams, could be used to prevent heart attacks in remote healthcare and ambulatory care settings, helping manage cardiovascular disease, which affects around 4 Billion Australians and kills over 100 people daily.

Application:

Arrhythmias segment is the fastest-growing segment in electrocardiogram sensors market share

The arrhythmias segment is the fastest-growing segment in the electrocardiogram sensors market share and is expected to hold the market share over the forecast period.

This market for ECG sensors globally is highly driven by arrhythmias in view of the urgency they present in effective diagnosis and monitoring solutions with which to meet the increasing burden of such irregular heart rhythms. Such conditions as atrial fibrillation, ventricular tachycardia, and bradycardia, which call for extremely continuous and accurate tracking of heart rhythm, have been the catalyst for the rapid adoption of advanced ECG sensors throughout clinical and personal healthcare. The increasing drive for wearable devices that detect real-time arrhythmias, like smartwatches and portable ECG monitors, has given the predicted boost in market revenue.

Technology innovations in sensors, such as AI integration and wireless connectivity, could definitely increase the accuracy and convenience of arrhythmia detection for early intervention and better patient outcomes. Additionally, the rising incidence of arrhythmias in the global world, which is greatly due to increased aging of the population, inactivity lifestyles, and the presence of cardiovascular conditions, makes ECG sensors irreplaceable tools in ensuring heart health and hence a potent driver of market growth.

Geographical Analysis

North America is expected to hold a significant position in the electrocardiogram sensors market share

North America holds a substantial position in the electrocardiogram sensors market and is expected to hold most of the market share due to advanced healthcare infrastructure, a high prevalence of cardiovascular diseases, and a growing inclination toward advanced diagnostic tools for heart health management.

Moreover, North America is also seeing a surge in the adoption of wearable and portable ECG monitoring devices, all against the backdrop of increasing usage of remote patient monitoring and telemedicine services, as boosted through extensive government initiatives and investments in digital health technologies for better early diagnosis and disease management. The development of the market is also aided by the presence of key industry players as well as continuous innovations in sensor technologies such as wireless and AI-enabled ECG devices. Furthermore, an intensely technology-based population and favorable reimbursement policies concerning cardiac diagnostic procedures withhold value to the end users for better adoption of ECG sensors in clinical and personal health applications.

For instance, in May 2024, Defibtech, a US manufacturer of life-saving medical equipment, has introduced dual-language AED models in their Lifeline VIEW and Lifeline ECG product lines. These models allow rescuers to choose English or Spanish as the spoken language with a simple touch of a button. The new AED models are designed to make the devices accessible to more of the population, thereby saving more lives from sudden cardiac arrest. Joseph Mullally, Senior Vice President of Commercial Operations for Defibtech, expressed his satisfaction with the additions.

Europe is growing at the fastest pace in the electrocardiogram sensors market

Europe holds the fastest pace in the electrocardiogram sensors market and is expected to hold most of the market share.

Growing burden of cardiovascular diseases because of this aging population and sedentary lifestyle is what's propelling the ECG sensors market in Europe, along with rising awareness on preventive healthcare. To boost the ECG market, government-sponsored healthcare systems and strong regulatory frameworks ensure the availability and adoption of advanced technologies. Awareness campaigns and initiatives have led to significant acceptance of these devices for continuous and wearable monitoring in the region, emphasizing early detection and management of heart conditions.

Innovations in small, wireless, and integrated AI technology ECG sensors have emerged through collaborative efforts of healthcare providers and technology developers to further increase their use in hospitals and outpatient settings as well as in homes. However, this region continues to stimulate the growth of demand concerning ECG sensors, hence making Europe a substantial contributor to this global market because of its research and development, as well as improvement in healthcare outcomes.

Competitive Landscape

The major global players in the electrocardiogram sensors market include Texas Instruments Inc, Movesense, Unimed Medical Supplies Inc., APK Technology Co., Ltd., Shenzhen Amydi-med Electronic Technology Co., Ltd, Monitor Health, Mobile Sense Technologies Inc., VitalSignum Oy, RONSEDA ELECTRONICS CO.,LTD, KEBORUI among others.

Emerging Players

The emerging players in the electrocardiogram sensors market include AliveCor, Qardio, Inc, FibriCheck and among others.

Key Developments

In June 2024, AliveCor has received FDA clearance for its AI-powered ECG interpretation system and a streamlined handheld ECG system. The pocket-sized system requires minimal training and uses only a single cable, detecting 35 cardiac conditions using a reduced leadset.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global electrocardiogram sensors market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Connectivity & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Connectivity
3.3. Snippet by Application
3.4. Snippet by End User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Technological Advancements
4.2. Restraints
- 4.2.1. Lack of Skilled Professionals
4.3. Opportunity
- 4.3.1. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Product type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
- 6.1.2. Market Attractiveness Index, By Product type
6.2. Wearable ECG Sensors *
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Patch ECG Sensors
6.4. Wireless ECG Sensors
6.5. Integrated ECG Devices

7. By Connectivity

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Connectivity
- 7.1.2. Market Attractiveness Index, By Connectivity
7.2. Wired*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Wireless

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Arrhythmia*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Myocardial Infarction
8.4. Others

9. By End User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals and Clinics*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Ambulatory Surgical Centers
9.4. Homecare Settings
9.5. Sports and Fitness Centers
9.6. Research Institutes

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Connectivity
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.7.1. U.S.
  - 10.2.7.2. Canada
  - 10.2.7.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Connectivity
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.7.1. Germany
  - 10.3.7.2. U.K.
  - 10.3.7.3. France
  - 10.3.7.4. Spain
  - 10.3.7.5. Italy
  - 10.3.7.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Connectivity
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.7.1. Brazil
  - 10.4.7.2. Argentina
  - 10.4.7.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Connectivity
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.7.1. China
  - 10.5.7.2. India
  - 10.5.7.3. Japan
  - 10.5.7.4. South Korea
  - 10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Connectivity
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Texas Instruments Inc*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Movesense
12.3. Unimed Medical Supplies Inc.
12.4. APK Technology Co., Ltd.
12.5. Shenzhen Amydi-med Electronic Technology Co., Ltd
12.6. Monitor Health
12.7. Mobile Sense Technologies, Inc.
12.8. VitalSignum Oy
12.9. RONSEDA ELECTRONICS CO.,LTD
12.10. KEBORUI (LIST NOT EXHAUSTIVE)